Myeloma UK is the only UK cancer organisation dealing specifically with myeloma and its related disorders
We fund research and support innovation, which will ultimately lead to safer and better treatment as well as to curative strategies in the longer term
Our Clinical Trial Network aims to systematically and rapidly conduct a portfolio of prioritised clinical trials of new drugs in myeloma, meaning that patients will benefit sooner from the new effective treatment combinations
We have a comprehensive range of services for patients, their families and carers, and healthcare professionals
Our innovative Myeloma Nurse Learning Programme is the only one of its type in the world
Over 750 haematology nurses receive our information to give to patients, families and carers
We funded the first evidenced-based guidelines for the diagnosis , treatment and management of myeloma
We campaign to ensure that every myeloma patient has access to and receives optimum treatment and care, regardless of their age, gender or postcode
Our Myeloma Infoline takes over 400 calls every month
There is a network of 50 Myeloma Support Groups across the country